If you’ve been diagnosed with Ehlers-Danlos Syndrome (EDS), Postural Orthostatic Tachycardia Syndrome (POTS), Mast Cell Activation Syndrome (MCAS), or chronic fatigue, you may have noticed that these conditions seem to travel together. Research increasingly recognizes a clinical cluster where these conditions overlap, share common mechanisms, and amplify each other’s symptoms.
At our practice, we see this pattern frequently, and understanding how these conditions connect is the first step toward feeling better.
What Are These Conditions?
[Hypermobile Ehlers-Danlos Syndrome](/rare-disease/hypermobile-ehlers-danlos-syndrome) (hEDS) is a connective tissue disorder characterized by joint hypermobility, chronic pain, skin that bruises easily, and/or tissue fragility throughout the body. Because connective tissue is everywhere, in your joints, blood vessels, gut lining, and around your nerves, hEDS can affect many organ systems.
Postural Orthostatic Tachycardia Syndrome (POTS) is a form of dysautonomia where your heart rate increases excessively when you stand up or exercise. Symptoms include dizziness, lightheadedness, brain fog, fatigue, palpitations, and exercise intolerance. Many people with POTS also experience nausea, bloating, and temperature regulation problems.
Mast Cell Activation Syndrome (MCAS) occurs when mast cells, an immune cell found throughout your body, release their chemical contents (including histamine, tryptase, and prostaglandins) too easily or too often. This can cause flushing, hives, GI distress, headaches, brain fog, rapid heart rate, and in severe cases, anaphylaxis.
Histamine Intolerance (HIT) is related but distinct from MCAS. In HIT, the body cannot break down histamine from food efficiently, usually due to low levels of the enzyme diamine oxidase (DAO). Symptoms overlap significantly with MCAS. Headaches, digestive upset, skin reactions, nasal congestion, allergies but the root cause is impaired histamine metabolism rather than inappropriate mast cell activation.
Chronic Fatigue Syndrome / Myalgic Encephalomyelitis (ME/CFS) involves profound, debilitating fatigue that doesn’t improve with rest, along with post-exertional malaise, cognitive dysfunction (“brain fog”), unrefreshing sleep, and pain. Many patients with ME/CFS have evidence of mast cell activation and autonomic dysfunction.
How Often Do These Conditions Overlap?
The overlap is striking. Research shows:
– Among patients with MCAS and digestive symptoms, nearly 24% also have EDS and 25% also have POTS. About 15% have all three conditions simultaneously.
– MCAS is found in approximately 31% of patients who have both POTS and EDS, compared to only 2% in those without these conditions.
– Among EDS patients broadly, MCAS is documented in about 5–8% using strict diagnostic criteria, though clinical experience suggests the true prevalence may be higher.
Why Do These Conditions Travel Together?
The emerging theory centers on connective tissue as the common thread:
Step 1: Abnormal Connective Tissue (hEDS)
In hEDS, connective tissue throughout the body is softer and more lax than normal. This affects blood vessels, the gut wall, and the tissue surrounding nerves and immune cells.
Step 2: Connective Tissue Affects Mast Cells (→ MCAS)
Mast cells live within connective tissue. When that tissue has abnormal structure and mechanical properties, it may change how mast cells behave, potentially lowering the threshold for them to release histamine and other inflammatory chemicals. Think of it as mast cells sitting in an unstable environment that keeps them on a hair trigger.
Step 3: Mast Cell Chemicals Affect Blood Vessels (→ POTS)
When mast cells release histamine and other vasodilators, blood vessels relax and expand. Combined with the already-lax blood vessels in hEDS, this causes excessive blood pooling in the legs when you stand. Your heart compensates by racing and you experience the dizziness, palpitations, and brain fog of POTS.
Step 4: Neuroinflammation Drives Fatigue (→ ME/CFS)
Mast cell chemicals don’t just affect blood vessels. They can cross into the brain, activate inflammatory cells called microglia, and create focal inflammation in the hypothalamus, the brain’s master regulator of energy, sleep, temperature, and stress responses. This neuroinflammation may be a central driver of the crushing fatigue, cognitive dysfunction, and autonomic instability seen in ME/CFS.
The Histamine Connection
Histamine plays a central role across all of these conditions:
– In MCAS, mast cells release excessive histamine internally
– In histamine intolerance, dietary histamine isn’t broken down properly
– Both lead to histamine overload, but through different mechanisms
– Many patients have both problems simultaneously
Histamine affects virtually every organ system: it dilates blood vessels (flushing, low blood pressure, POTS symptoms), stimulates stomach acid (heartburn, nausea), contracts smooth muscle in the gut and airways (cramping, diarrhea, wheezing), and acts as a neurotransmitter in the brain (insomnia, anxiety, brain fog).
This is why patients with these overlapping conditions often feel like “everything is effecting everything” because biochemically, it is.
The COVID Connection
COVID-19 infection may unmask or worsen all components of this triad. Research shows that mast cell activation patterns in Long COVID mirror those seen in ME/CFS and small-fiber neuropathy. Many patients report that their symptoms began or dramatically worsened after a COVID infection.
Getting Properly Diagnosed
Proper diagnosis requires:
For MCAS, all three criteria must be met:
1. Episodic symptoms affecting two or more organ systems (skin, GI, cardiovascular, respiratory, neurologic)
2. Objective evidence of elevated mast cell mediators during an episode: serum tryptase drawn within 1–4 hours of symptoms, or 24-hour urine for N-methylhistamine, prostaglandin D2 metabolites, or leukotriene E4, but these tests can be difficult to get at the time of a flare, and expensive.
3. Improvement with medications that target mast cell mediators
For histamine intolerance: clinical response to a low-histamine elimination diet.
For POTS: a tilt table test or active standing test (NASA Lean test) showing heart rate increase of 30+ beats per minute (or over 120 bpm) within 10 minutes of standing, without a significant drop in blood pressure.
For hEDS: clinical evaluation using the 2017 diagnostic criteria, assessing joint hypermobility (Beighton score), skin and tissue features, and family history. Many physical therapists can do this testing.
What to Do Next
If this pattern sounds familiar, the most important step is finding a provider who understands these overlapping conditions and can coordinate a systematic diagnostic workup. Many patients spend years seeing specialists who each address one piece of the puzzle without recognizing the whole picture.
In our companion article, “Treating the Triad: A Comprehensive Approach to MCAS, Histamine Intolerance, and Related Conditions,” we outline the specific treatment strategies that can help manage this complex but treatable cluster of conditions.
